Shingrix Recipients Were 10 Percent Less Likely to Be Diagnosed with Heart Disease Than Zostavax Recipients

An Oxford-led study of more than 70,000 older adults found Shingrix recipients had 10 percent fewer heart disease diagnoses than Zostavax recipients.

Have A Referral?